Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer

Radioimmunotherapy (RIT) has demonstrated efficacy with acceptable toxicity leading to approval in non-Hodgkin’s lymphoma, but has been slower to develop for the treatment of advanced solid tumors. Prostate cancer (PC) represents a good candidate for RIT based upon high exposure to circulating antib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Tagawa, Scott T., Akhtar, Naveed H., Nikolopoulou, Anastasia, Kaur, Gurveen, Robinson, Brian, Kahn, Renee, Vallabhajosula, Shankar, Goldsmith, Stanley J., Nanus, David M., Bander, Neil H.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2013
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3752585/
https://ncbi.nlm.nih.gov/pubmed/23986881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2013.00214
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars